|
|
|
|
|
Dr. [Last Name],
|
|
We are pleased to share that ENTRESTO® has increased unrestricted access to more patients without a prior authorization. Seeing these numbers really is believing.
|
|
•
|
94% of Medicare Part D patients have preferred coverage for ENTRESTO without a prior authorization1
|
|
•
|
79% of Commercially insured patients have preferred access to ENTRESTO without a prior authorization1
|
|
|
|
|
Dr. [Lastname],
|
|
We are pleased to share that ENTRESTO® has increased unrestricted access to more patients without a prior authorization. Seeing these numbers really is believing.
|
|
•
|
94% of Medicare Part D patients have preferred coverage for ENTRESTO without a prior authorization1
|
|
•
|
79% of Commercially insured patients have preferred access to ENTRESTO without a prior authorization1
|
|
|
|
Please see full Prescribing Information, including Boxed WARNING.
|
|
Inclusion of formulary status does not imply superior clinical efficacy or safety.
|
|
The information provided in this communication is not a guarantee of coverage or payment (partial or full). Actual benefits are determined by each plan administrator in accordance with its respective policy and procedures. Nothing herein may be construed as an endorsement, approval, recommendation, representation or warranty of any kind by any plan or insurer referenced herein. This communication is solely the responsibility of Novartis Pharmaceuticals Corporation.
|
|
Reference: 1. Data on file. ENTRESTO Access. Data from May 15, 2020. Novartis Pharmaceuticals Corporation. Updated June 10, 2020.
|
|
If you prefer not to receive email communications about ENTRESTO, please click here.
|
|
If you have any questions concerning email marketing or marketing communications from Novartis Pharmaceuticals Corporation, please call 1-888-NOW-NOVA (1-888-669-6682), Monday through Friday, 8:30 AM through 5:00 PM ET.
|
|
For more information, please visit the Novartis Pharmaceuticals Corporation Privacy Policy.
|
|
ENTRESTO and the ENTRESTO logo are registered trademarks of Novartis AG.
|
|
|
|
|
|
Novartis Pharmaceuticals Corporation
One Health Plaza
East Hanover, New Jersey 07936-1080
|
|
|
|
|
|
|
|
Novartis Pharmaceuticals Corporation
One Health Plaza
East Hanover, New Jersey 07936-1080
|
|
© 2020 Novartis
|
|
Unsubscribe | Privacy Policy
|
|
6/20 T-ETR-1390539
|
|
|
